1 Min Read
Sept 20 (Reuters) - Glenmark Pharmaceuticals Ltd
* Says receives ANDA approval for nitroglycerin sublingual tablets usp, 0.3 mg, 0.4 mg, and 0.6 mg Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.